PATENT CLAIM ANALYSIS

Application Number: 16157050
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-07
Patent Classification: ["424", "450000"]

Abstract:
Disclosed herein are pharmaceutical compositions that comprise “blends” of lipid nanoparticles and related methods of using such blended compositions to deliver polynucleotides to one or more target cells, tissues or organs. The blended compositions are generally characterized as being able to efficiently deliver polynucleotides to target cells and by their ability to enhance the expression of such polynucleotides and the production of functional proteins by target cells.

Claim (Index 93):
The method of  claim 83 , wherein the expression of the protein or the peptide encoded by the first mRNA following the administration of the pharmaceutical composition to the subject exceeds the expression of the protein or the peptide encoded by the first mRNA administered with the first lipid nanoparticle but without the second lipid nanoparticle by at least about five-fold, or by at least about ten-fold.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775818', '14124615', '15887693', '14959453', '15368280']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7991502299757806
- 35 USC 102 Novelty (BERT): 0.6796720297970512
- Combined Prediction Score: 0.7872024099579077
- Mean Citation Score: 512.98415
- Max Citation Score: 759.15955
- Similarity Product: 684.5865348906606

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test